NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
This article is dedicated to a monogenic polysystemic disease — mucoviscidosis; its course severity and prognosis are to a large extend determined by the degree of lung affection, infection and chronic inflammatory process development in the airways. The authors show the derangement of the quality o...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2012-10-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/294 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | This article is dedicated to a monogenic polysystemic disease — mucoviscidosis; its course severity and prognosis are to a large extend determined by the degree of lung affection, infection and chronic inflammatory process development in the airways. The authors show the derangement of the quality of life in children with mucoviscidosis and examine approaches to the therapy adherence issues, which is important for the treatment effectiveness. On the example of their own study and international experience they show the effectiveness of the inhalation technique of the drug delivery to a pathological nidus. |
|---|---|
| ISSN: | 1727-5776 2500-3089 |